Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | NCF1 | P14598 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 1/20 | 0.54 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.53 |
| ▸ | ACP1 | P24666 | 2/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.51 |
| ▸ | CD38 | P28907 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | GALR3 | O60755 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3058825 | 0.90 | CYP2C19 (0.64) | MEN1KMT2AGPR35CYP2C19ALDH1A1 | |
| SCHEMBL3056723 | 0.86 | ACP1 (0.62) | MEN1KMT2AGPR35CYP2C19NCF1 | |
| SCHEMBL3059015 | 0.81 | CD38 (0.61) | MEN1KMT2AGPR35CYP2C19NCF1 | |
| SCHEMBL9363750 | 0.77 | MEN1 (0.61) | MEN1KMT2AGPR35CYP2C19NCF1 | |
| SCHEMBL3058636 | 0.77 | CD38 (0.56) | CYP2C19ACP1OPRK1CD38HTT | |
| SCHEMBL3054345 | 0.76 | CD38 (0.53) | MEN1KMT2ACYP2C19ACP1OPRK1 | |
| Hydrochloric Acid SCHEMBL9494706 | 0.76 | CD38 (0.55) | CYP2C19ACP1OPRK1CD38HTT | |
| SCHEMBL15673549 | 0.75 | HDAC6 (0.64) | MEN1KMT2ALMNAMAPTAPP | |
| SCHEMBL7500041 | 0.75 | CYP2C19 (0.69) | MEN1KMT2ACYP2C19ALDH1A1NCF1 | |
| SCHEMBL6617289 | 0.75 | MEN1 (0.59) | MEN1KMT2AGPR35CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210161810-A1 | Pharmaceutical Compositions Including Low Dosages of Desmopressin | FIRST GENERATION CAPITAL INC. (CA) | 2021-06-03 | — | — | US | disclosed |
| US-9504647-B2 | Pharmaceutical formulations of desmopressin | FERRING B.V. (NL) | 2016-11-29 | — | — | US | disclosed |
| US-20160175246-A1 | PHARMACEUTICAL FORMULATIONS | FERRING B.V. (NL) | 2016-06-23 | — | — | US | disclosed |
| US-8420670-B2 | 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy | ABBOTT LABORATORIES (US) | 2013-04-16 | — | — | US | disclosed |
| US-8420670-B2 | 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy | ABBOTT LABORATORIES (US) | 2013-04-16 | — | — | US | disclosed |
| US-8420670-B2 | 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy | ABBOTT LABORATORIES (US) | 2013-04-16 | — | — | US | disclosed |
| US-20120322734-A1 | Pharmaceutical Compositions Including Low Dosages of Desmopressin | SERENITY PHARMACEUTICALS LLC | 2012-12-20 | — | — | US | disclosed |
| US-7799761-B2 | Pharmaceutical compositions including low dosages of desmopressin | ALLERGAN, INC. (US) | 2010-09-21 | — | — | US | disclosed |
| US-20100222346-A1 | 4-BENZYLAMINOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY | ABBVIE DEUTSCHLAND GMBH & CO KG (DE) | 2010-09-02 | — | — | US | disclosed |
| US-20100222346-A1 | 4-BENZYLAMINOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY | ABBVIE DEUTSCHLAND GMBH & CO KG (DE) | 2010-09-02 | — | — | US | disclosed |
| EP-2178842-A2 | 4-BENZYLAMINOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE | Abbott GmbH & Co. KG (DE) | 2010-04-28 | — | — | EP | disclosed |
| US-20100056436-A1 | Pharmaceutical Compositions Including Low Dosages of Desmopressin | SERENITY PHARMACEUTICALS LLC | 2010-03-04 | — | — | US | disclosed |
| US-7579321-B2 | Pharmaceutical compositions including low dosages of desmopressin | REPRISE BIOPHARMACEUTICS, LLC (US) | 2009-08-25 | — | — | US | disclosed |
| WO-2009024611-A2 | 4-BENZYLAMINOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE | ABBOTT GMBH & CO. KG (DE) | 2009-02-26 | — | — | WO | disclosed |
| WO-2009024611-A2 | 4-BENZYLAMINOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE | ABBOTT GMBH & CO. KG (DE) | 2009-02-26 | — | — | WO | disclosed |
| US-20090005432-A1 | PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN | SERENITY PHARMACEUTICALS LLC | 2009-01-01 | — | — | US | disclosed |
| US-20080274951-A1 | PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN | FIRST GENERATION CAPITAL INC. (CA) | 2008-11-06 | — | — | US | disclosed |
| US-7405203-B2 | Pharmaceutical compositions including low dosages of desmopressin | REPRISE BIOPHARMACEUTICS, LLC (US) | 2008-07-29 | — | — | US | disclosed |
| US-20070265207-A1 | Pharmaceutical Compositions Including Low Dosages of Desmopressin | Acerus Pharmaceuticals USA, LLC | 2007-11-15 | — | — | US | disclosed |
| US-20040138098-A1 | Pharmaceutical compositions including low dosages of desmopressin | FIRST GENERATION CAPITAL INC. (CA) | 2004-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222346-A1 | 4-BENZYLAMINOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY | GDI2, GDI1, NQO2 | MEN1 1704/4885KMT2A 1738/4885GPR35 727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.